Alignment Healthcare exec plans 26K share sale

A director and EVP at ALHC filed a Rule 144 notice to sell shares primarily to cover tax obligations on vested equity awards.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) received a Rule 144 notice from director and EVP, Corporate Affairs Joseph Konowiecki covering a proposed sale of 26,000 shares of common stock through E-Trade, with an aggregate market value of $226,460, and an approximate sale date of September 17, 2026 on the Nasdaq Stock Market.

The shares relate to common stock acquired upon vesting of restricted stock units granted on September 14, 2023 under the company’s 2021 Equity Incentive Plan, with 43,554 shares acquired on that date. The notice states the transaction is a sale-to-cover for tax withholding and not a discretionary trade. It also lists prior three-month sales under a 10b5-1 sales plan totaling 75,000 shares for approximately $1.73 million.

Key Figures

Shares proposed to be sold: 26,000 shares Aggregate market value of proposed sale: $226,460 Shares outstanding: 207,435,149 shares +4 more

7 metrics

Shares proposed to be sold 26,000 shares Common stock covered by the Rule 144 notice

Aggregate market value of proposed sale $226,460 Value of 26,000 shares of common stock in the Rule 144 notice

Shares outstanding 207,435,149 shares Common stock outstanding for Alignment Healthcare, Inc.

Shares acquired via RSU vesting 43,554 shares Common stock acquired upon RSU vesting on September 14, 2023

Prior sale June 18, 2026 25,000 shares for $550,000 Sale under a 10b5-1 Sales Plan

Prior sale June 26, 2026 25,000 shares for $575,000 Sale under a 10b5-1 Sales Plan

Prior sale July 1, 2026 25,000 shares for $600,000 Sale under a 10b5-1 Sales Plan

Key Terms

Rule 144, 10b5-1 Sales Plan, restricted stock units, sale-to-cover transaction

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for Joseph Konowiecki 1100 W. Town & Country Road"

A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.

restricted stock units financial

"The Common Stock was acquired through the vesting of restricted stock units granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sale-to-cover transaction financial

"Shares sold pursuant to a sale-to-cover transaction and does not represent"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ALHC disclose about Joseph Konowiecki?

The filing discloses that director and EVP, Corporate Affairs Joseph Konowiecki filed a Rule 144 notice for a proposed sale of 26,000 shares of Alignment Healthcare common stock, largely tied to vested restricted stock units under the company’s 2021 Equity Incentive Plan.

How many ALHC shares are covered by the new Rule 144 notice?

The notice covers a proposed sale of 26,000 shares of Alignment Healthcare common stock through broker E-Trade. The aggregate market value of these shares is listed as $226,460, with an approximate sale date of September 17, 2026 on the Nasdaq Stock Market.

What is the source of the ALHC shares to be sold under this Form 144?

The common stock was acquired through the vesting of restricted stock units granted on September 14, 2023 under Alignment Healthcare’s 2021 Equity Incentive Plan. The filing reports 43,554 shares acquired on that vesting date.

Is the planned ALHC share sale characterized as discretionary trading?

No. The remarks state the shares are being sold pursuant to a sale-to-cover transaction and that the transaction does not represent a discretionary trade by the reporting person. The actual shares sold will depend on tax withholding rates and the stock price at the time of sale.

What ALHC stock sales has Joseph Konowiecki reported in the past three months?

The Form 144 lists three prior sales under a 10b5-1 Sales Plan: 25,000 shares on June 18, 2026 for $550,000; 25,000 shares on June 26, 2026 for $575,000; and 25,000 shares on July 1, 2026 for $600,000.

How many ALHC shares are outstanding according to this Form 144?

The filing reports that there are 207,435,149 shares of Alignment Healthcare common stock outstanding. This figure is presented in the securities information section as the total shares outstanding for the class of stock referenced in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 05:53 PM Accepted by SEC EDGAR 09/16/2026 - 05:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001209523
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	Joseph Konowiecki
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director / EVP, Corporate Affairs

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	26000	226460	207435149	09/17/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/14/2023	The Common Stock was acquired through the vesting of restricted stock units granted on 09/14/2023 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			43554	09/14/2023	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for Joseph Konowiecki 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	07/01/2026	25000	600000
10b5-1 Sales Plan for Joseph Konowiecki 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/26/2026	25000	575000
10b5-1 Sales Plan for Joseph Konowiecki 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/18/2026	25000	550000

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	09/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph Konowiecki
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)